Compound information
- Natural Products
- ZC409969
- Molecular Formula
- C12H16NO7P
- Molecular Weight
- 317.066438482 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-(benzyloxycarbonylamino)-2-dimethoxyphosphoryl-acetic acid
- InChI
- InChI=1S/C12H16NO7P/c1-18-21(17,19-2)10(11(14)15)13-12(16)20-8-9-6-4-3-5-7-9/h3-7,10H,8H2,1-2H3,(H,13,16)(H,14,15)/t10-/m1/s1
- InChI Key
- RTXDKVFNAOMDFV-SNVBAGLBSA-N
- SMILES
- COP(=O)(OC)[C@@H](NC(=O)OCc1ccccc1)C(=O)O
- Source
- ZINC000097757462
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 1 |
Heteroatom Count | 9 | Rotatable Bond Count | 7 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 111.16 Å2 | LogP | 0.815 |
LogS | -2.255 | LogD | -0.674 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.002 | Pgp substrate | 0.002 |
HIA | 0.948 | F20 % | 0.989 |
F30 % | 0.046 | Caco-2 | -5.598 |
MDCK | -5.316 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.783 | PPB | 54.777 |
VD | 0.408 | Fu | 0.54 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.004 | CYP1A2 substrate | 0.567 |
CYP2A6 substrate | 0.591 | CYP2B6 substrate | 0.62 |
CYP2C19 inhibitor | 0.066 | CYP2C19 substrate | 0.805 |
CYP2C8 substrate | 0.598 | CYP2C9 inhibitor | 0.034 |
CYP2C9 substrate | 0.965 | CYP2D6 inhibitor | 0.01 |
CYP2D6 substrate | 0.227 | CYP2E1 substrate | 0.749 |
CYP3A4 inhibitor | 0.014 | CYP3A4 substrate | 0.171 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.763 | CL | 2.63 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.01 | Hepatotoxicity | 0.407 |
Mutagenicity | 0.832 | Rat Oral Acute Toxicity | 0.083 |
FDAMDD | 0.058 | Skin Sensitization | 0.015 |
Carcinogenicity | 0.002 | Eye Corrosion | 0.003 |
Eye Irritation | 0.068 | Respiratory Toxicity | 0.034 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.09 | IGC50 | 1.872 |
LC50FM | 3.094 | LC50DM | 5.803 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.403 | NR-AR-LBD | 0.332 |
NR-AhR | 0.015 | NR-Aromatase | 0.025 |
NR-ER | 0.354 | NR-ER-LBD | 0.403 |
NR-PPAR-gamma | 0.465 | SR-ARE | 0.31 |
SR-ATAD5 | 0.265 | SR-HSE | 0.019 |
SR-MMP | 0.013 | SR-p53 | 0.027 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.